95 percent of clinical trial participants reported better sleep in four weeks BELFAST, Northern Ireland, Oct. 28, 2024 /PRNewswire/ -- Neurovalens, a global health-tech leader in neurotechnology, has launched its first product, Modius Sleep, to treat chronic insomnia. Neurovalens received...
Product Launch: Modius Sleep FDA-Cleared Non-Invasive Device that Treats Chronic Insomnia is Now Available for Purchase
Seaking AlphaSeeking Alpha / Seaking Alpha 3 hours ago 1 Views
Comments